US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 8.670
  • -0.640-6.87%
Trading Mar 25 13:12 ET
897.50MMarket Cap-1.65P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
59.55%57.88M
771.57%12.87M
-24.02%9.11M
-48.82%6.96M
129.53%28.94M
-30.40%36.28M
-114.12%-1.92M
-9.60%11.99M
-3.11%13.59M
12.03%12.61M
Operating revenue
59.55%57.88M
771.57%12.87M
-24.02%9.11M
-48.82%6.96M
129.53%28.94M
-30.40%36.28M
-114.12%-1.92M
-9.60%11.99M
-3.11%13.59M
12.03%12.61M
Cost of revenue
Gross profit
Operating expense
7.36%592.14M
8.22%149.32M
7.53%153.88M
0.05%146M
14.75%142.94M
8.09%551.57M
11.58%137.98M
20.46%143.1M
29.91%145.93M
-19.89%124.56M
Selling and administrative expenses
8.01%125.83M
11.90%32.44M
3.73%30.5M
3.72%31.79M
13.27%31.09M
29.00%116.5M
22.72%28.99M
32.77%29.4M
38.50%30.65M
22.52%27.45M
-General and administrative expense
8.01%125.83M
11.90%32.44M
3.73%30.5M
3.72%31.79M
13.27%31.09M
29.00%116.5M
22.72%28.99M
32.77%29.4M
38.50%30.65M
22.52%27.45M
Research and development costs
7.18%466.31M
7.25%116.88M
8.52%123.38M
-0.93%114.21M
15.17%111.85M
3.59%435.07M
8.94%108.98M
17.64%113.7M
27.80%115.28M
-27.03%97.12M
Operating profit
-3.68%-534.26M
2.46%-136.45M
-10.42%-144.77M
-5.07%-139.04M
-1.83%-114M
-12.47%-515.29M
-27.07%-139.89M
-24.24%-131.11M
-34.62%-132.33M
22.38%-111.96M
Net non-operating interest income expense
-4.06%47.81M
-14.67%10.63M
-4.85%12.12M
-1.83%12.42M
5.44%12.63M
483.38%49.83M
132.70%12.46M
555.01%12.74M
1,699.86%12.65M
2,118.52%11.98M
Non-operating interest income
-4.06%47.81M
-14.67%10.63M
-4.85%12.12M
-1.83%12.42M
5.44%12.63M
483.38%49.83M
132.70%12.46M
555.01%12.74M
1,699.86%12.65M
2,118.52%11.98M
Other net income (expense)
-106.99%-32.57M
34.81%-3.08M
20.56%-3.06M
-408.85%-20.35M
-92.66%-6.07M
35.95%-15.73M
45.49%-4.73M
60.01%-3.86M
-29.87%-4M
0.57%-3.15M
Gain on sale of security
---32.57M
---3.08M
---3.06M
---20.35M
---6.07M
----
----
----
----
----
Earnings from equity interest
--0
--0
--0
--0
--0
-41.10%-15.63M
-45.57%-4.73M
-110.31%-3.86M
-23.00%-4M
-11.04%-3.05M
Special income (charges)
--0
--0
--0
--0
--0
99.26%-100K
--0
--0
--0
76.25%-100K
-Less：Restructuring and merger&acquisition
--0
--0
--0
--0
--0
-99.26%100K
--0
--0
--0
-76.25%100K
Income before tax
-7.86%-519.02M
2.47%-128.9M
-11.04%-135.71M
-18.83%-146.98M
-4.18%-107.44M
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
Income tax
Net income
-7.86%-519.02M
2.47%-128.9M
-11.04%-135.71M
-18.83%-146.98M
-4.18%-107.44M
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
Net income continuous Operations
-7.86%-519.02M
2.47%-128.9M
-11.04%-135.71M
-18.83%-146.98M
-4.18%-107.44M
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
Minority interest income
Net income attributable to the parent company
-7.86%-519.02M
2.47%-128.9M
-11.04%-135.71M
-18.83%-146.98M
-4.18%-107.44M
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.86%-519.02M
2.47%-128.9M
-11.04%-135.71M
-18.83%-146.98M
-4.18%-107.44M
-1.48%-481.19M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
Basic earnings per share
3.14%-5.25
13.01%-1.27
2.90%-1.34
-8.57%-1.52
4.27%-1.12
12.01%-5.42
-4.29%-1.46
7.38%-1.38
-5.26%-1.4
40.31%-1.17
Diluted earnings per share
3.14%-5.25
13.01%-1.27
2.90%-1.34
-8.57%-1.52
4.27%-1.12
12.01%-5.42
-4.29%-1.46
7.38%-1.38
-5.26%-1.4
40.31%-1.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 59.55%57.88M771.57%12.87M-24.02%9.11M-48.82%6.96M129.53%28.94M-30.40%36.28M-114.12%-1.92M-9.60%11.99M-3.11%13.59M12.03%12.61M
Operating revenue 59.55%57.88M771.57%12.87M-24.02%9.11M-48.82%6.96M129.53%28.94M-30.40%36.28M-114.12%-1.92M-9.60%11.99M-3.11%13.59M12.03%12.61M
Cost of revenue
Gross profit
Operating expense 7.36%592.14M8.22%149.32M7.53%153.88M0.05%146M14.75%142.94M8.09%551.57M11.58%137.98M20.46%143.1M29.91%145.93M-19.89%124.56M
Selling and administrative expenses 8.01%125.83M11.90%32.44M3.73%30.5M3.72%31.79M13.27%31.09M29.00%116.5M22.72%28.99M32.77%29.4M38.50%30.65M22.52%27.45M
-General and administrative expense 8.01%125.83M11.90%32.44M3.73%30.5M3.72%31.79M13.27%31.09M29.00%116.5M22.72%28.99M32.77%29.4M38.50%30.65M22.52%27.45M
Research and development costs 7.18%466.31M7.25%116.88M8.52%123.38M-0.93%114.21M15.17%111.85M3.59%435.07M8.94%108.98M17.64%113.7M27.80%115.28M-27.03%97.12M
Operating profit -3.68%-534.26M2.46%-136.45M-10.42%-144.77M-5.07%-139.04M-1.83%-114M-12.47%-515.29M-27.07%-139.89M-24.24%-131.11M-34.62%-132.33M22.38%-111.96M
Net non-operating interest income expense -4.06%47.81M-14.67%10.63M-4.85%12.12M-1.83%12.42M5.44%12.63M483.38%49.83M132.70%12.46M555.01%12.74M1,699.86%12.65M2,118.52%11.98M
Non-operating interest income -4.06%47.81M-14.67%10.63M-4.85%12.12M-1.83%12.42M5.44%12.63M483.38%49.83M132.70%12.46M555.01%12.74M1,699.86%12.65M2,118.52%11.98M
Other net income (expense) -106.99%-32.57M34.81%-3.08M20.56%-3.06M-408.85%-20.35M-92.66%-6.07M35.95%-15.73M45.49%-4.73M60.01%-3.86M-29.87%-4M0.57%-3.15M
Gain on sale of security ---32.57M---3.08M---3.06M---20.35M---6.07M--------------------
Earnings from equity interest --0--0--0--0--0-41.10%-15.63M-45.57%-4.73M-110.31%-3.86M-23.00%-4M-11.04%-3.05M
Special income (charges) --0--0--0--0--099.26%-100K--0--0--076.25%-100K
-Less：Restructuring and merger&acquisition --0--0--0--0--0-99.26%100K--0--0--0-76.25%100K
Income before tax -7.86%-519.02M2.47%-128.9M-11.04%-135.71M-18.83%-146.98M-4.18%-107.44M-1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M
Income tax
Net income -7.86%-519.02M2.47%-128.9M-11.04%-135.71M-18.83%-146.98M-4.18%-107.44M-1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M
Net income continuous Operations -7.86%-519.02M2.47%-128.9M-11.04%-135.71M-18.83%-146.98M-4.18%-107.44M-1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M
Minority interest income
Net income attributable to the parent company -7.86%-519.02M2.47%-128.9M-11.04%-135.71M-18.83%-146.98M-4.18%-107.44M-1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.86%-519.02M2.47%-128.9M-11.04%-135.71M-18.83%-146.98M-4.18%-107.44M-1.48%-481.19M-16.54%-132.16M-7.94%-122.22M-22.85%-123.68M29.79%-103.13M
Basic earnings per share 3.14%-5.2513.01%-1.272.90%-1.34-8.57%-1.524.27%-1.1212.01%-5.42-4.29%-1.467.38%-1.38-5.26%-1.440.31%-1.17
Diluted earnings per share 3.14%-5.2513.01%-1.272.90%-1.34-8.57%-1.524.27%-1.1212.01%-5.42-4.29%-1.467.38%-1.38-5.26%-1.440.31%-1.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+2.68%
Ecopetrol
EC
+2.43%
Adobe
ADBE
+2.34%
Strategy
MSTR
+1.74%
Meta Platforms
META
+1.68%

Unlock the Full List

Investment Theme ARK Portfolio
ARK Portfolio
Intraday+0.64%
Gene Editing
Gene Editing
Intraday-0.90%